Medexus Pharmaceuticals Inc. (MEDXF)
OTCMKTS · Delayed Price · Currency is USD
2.049
-0.009 (-0.44%)
Oct 29, 2025, 1:04 PM EDT
Medexus Pharmaceuticals Market Cap
Medexus Pharmaceuticals has a market cap or net worth of $67.2 million as of October 29, 2025. Its market cap has increased by 45.28% in one year.
Market Cap
67.20M
Enterprise Value
79.53M
Revenue
105.66M
Ranking
n/a
PE Ratio
83.37
Stock Price
$2.05
Market Cap Chart
Since December 27, 2013, Medexus Pharmaceuticals's market cap has increased from 30.10M to 67.20M, an increase of 123.23%. That is a compound annual growth rate of 7.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 67.20M | 13.13% |
| Dec 31, 2024 | 59.40M | 29.86% |
| Dec 29, 2023 | 45.74M | 48.80% |
| Dec 30, 2022 | 30.74M | -23.08% |
| Dec 31, 2021 | 39.97M | -48.56% |
| Dec 31, 2020 | 77.70M | 82.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 655.03M |
| Glass House Brands | 559.28M |
| Northwest Biotherapeutics | 385.44M |
| Silence Therapeutics | 345.28M |
| CytoDyn | 313.10M |
| Nika Pharmaceuticals | 312.10M |
| American Oncology Network | 302.09M |